Is isolated palatal anomaly an indication to screen for 22q11 region deletion?
OBJECTIVE: Velocardiofacial syndrome (VCFS) is the most common multiple anomaly disorder associated with palatal clefting. Cytogenetic hemizygous deletion of 22q11 region is found in 80% of patients. The frequency of 22q11 deletion in patients presenting with isolated palatal anomalies has not been fully assessed. Our objective was to determine the frequency of the deletion in patients with isolated palatal anomalies. DESIGN: Patients were referred because of velopharyngeal insufficiency because of isolated congenital palatal anomalies. Diagnosis of palatal anomalies was confirmed by videonasopharyngoscopy, multiview videofluoroscopy and cephalometry. Other clinical findings suggestive of VCFS were sought, and subjects with these characteristics were excluded from the study. Peripheral blood samples from all patients were analyzed cytogenetically utilizing fluorescent in situ hybridization for the 22q11 region. RESULTS: Thirty-eight patients aged 3 to 31 years were included in the stud
Related Questions
- Every time I search for STS markers in dbSNP, dbSNP returns a screen that says that no SNPs were found in my region of interest. What am I doing wrong?
- What values do I use to screen / evaluate exposure via food chain exposure? Does Region 3 have screening values that address this route of exposure?
- Where do I change the Region, State/Province, and City that display on the screen I use to select the workcodes I will be using?
